期刊文献+

子宫内膜癌EphB4、ERα和ERβ的表达及意义 被引量:2

原文传递
导出
摘要 目的:研究EphB4、ERα和ERβ等各自的蛋白在子宫内膜癌(EC)中的表达及意义。方法:用SP法检测71例EC组织中EphB4、ERα和ERβ等各自蛋白的表达水平。结果:EphB4、ERα和ERβ的蛋白在71例EC组织中表达的阳性率分别为69.3%、52.3%和60.6%。EC组织中EphB4蛋白的阳性率与组织学分级、淋巴结转移、临床分期和年龄显著相关(P<0.05),ERα蛋白表达的阳性率与EC的淋巴结转移、病理类型、组织学分级和临床分期显著相关(P<0.05),ERβ蛋白的阳性率与淋巴结转移显著相关(P<0.05)。EphB4蛋白的阳性率与ERα、ERβ蛋白的阳性率均显著相关(P<0.05)。结论:EphB4、ERα和ERβ可能与EC的发生、发展有关,联合检测对EC的生物学行为的客观评估可提供帮助,可用来指导临床治疗和预测预后。
作者 赵玉斌
出处 《中国妇幼保健》 CAS 北大核心 2014年第28期4631-4634,共4页 Maternal and Child Health Care of China
  • 相关文献

参考文献4

二级参考文献41

共引文献23

同被引文献26

  • 1JonathanS,BerekN.妇科学[M].北京:人民卫生出版社,2008.
  • 2Mendes KN, Nicorici D, Cogdell D, et al. Analysis of sig- naling pathways in 90 cancer cell lines by protein lysate array[J]. Journal of Proteome Research,2007,6(7): 2753- 2767.
  • 3Su HY, Lai HC,Lin YW,et al. Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresis- tance of ovarian cancer through Wnt signaling pathway[J]. International Journal of Cancer, 2010,127 (3) : 555-567.
  • 4Maulik G,Shrikhande A,Kijima T,et al. Role of the hep- atocyte growth factor receptor, e-met,in oncogenesis and potential for therapeutic inhibition[J]. Cytokine & Growth Factor Reviews, 2002,13 ( 1 ) : 41-59.
  • 5Kammula US, Kuntz E J, Francone TD, et al. Molecular co- expression of the c-met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcome [J]. Cancer Letters, 2007,248 (2) : 219- 228.
  • 6Hunter AM,LaCasse EC,Korneluk RG. The inhibitors of apoptosis (IAPs) as cancer targets [J]. Apoptosis, 2007,12 (9) : 1543-1568.
  • 7Takeuchi H, Kim J, Fujimoto A, et al. X-linked inhibitor of apoptosis protein expression level in colorectal cancer is regulated by hepatocyte growth Factor/C-met pathway via Akt signaling[J]. Clinical Cancer Research,2005,11 (21) : 7621-7628.
  • 8Guseva NV, Dessus-Babus SC, Whittimore JD, et al. Char- acterization of estrogen-responsive epithelial cell lines and their infectivity by genital Chlamydia traehomatis[J]. Microbes and Infection, 2005,7 (15) : 1469-1481.
  • 9Ma PC, Maulik G, Christensen J, et al. c-met: Structure, functions and potential for therapeutic inhibition[J]. Can- cer and Metastasis Reviews, 2003,22(4) : 309-325.
  • 10Abidoye Oyewale, Murukurthy Nadh, Salgia Ravi. Review of clinic trials:Agents targeting c-Met[J]. Rev Recent Clin Trials, 2007,2 (2) : 143 - 147.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部